$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
宗格替尼(Zongertinib)的详细说明书:作用与功效,用法用量,副作用,注意事项等
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)的副作用和不良反应
2025-10-19 11:44:20
Check Details
FDA批准西米普利单抗(Cemiplimab)作为首个用于晚期基底细胞癌患者的免疫疗法
2025-10-19 11:44:20
Check Details
FDA批准西米普利单抗(Cemiplimab)用于晚期皮肤鳞状细胞癌
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)是治疗什么疾病的
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)的注意事项和药物相互作用
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)国内价格是多少
2025-10-19 11:44:20
Check Details
2025年宗格替尼(Zongertinib)最新价格是多少钱一盒?
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)怎么购买
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)的用法用量
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)中文说明书
2025-10-19 11:44:20
Check Details
宗格替尼(Zongertinib)的用法用量:用药指南,剂量调整
2025-10-19 11:44:20
Check Details
1
2
...
9013
9014
9015
9016
9017
9018
9019
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
2
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
3
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
4
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
5
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
6
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
7
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
8
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
9
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
10
Complete Guide to Dosage and Dose Adjustment of Entrectinib
11
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
12
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment